Qihan Biotech

About:

Qihan Biotech is a gene-editing organ transplantation technology developer.

Website: http://www.qihanbio.com/

Top Investors: ARCH Venture Partners, Matrix Partners China, HongShan, Alta Partners, Legend Star

Description:

Qihan Biotech is a biomedical company based on genetic technology. Kaixin Bio ’s mission is to create a new world where patients do n’t have to wait for organ transplants. We are committed to using the world's advanced gene editing technology to produce safe and effective cells, tissues and organs that can be used for human transplantation, and to solve the serious shortage of organ transplant donors in China and the world.

Total Funding Amount:

$116M

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2017-01-01

Contact Email:

info(AT)qihanbio.com

Founders:

Luhan Yang

Number of Employees:

101-250

Last Funding Date:

2023-09-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai